Key result
Depression and anxiety are common in HF and CAD, linked to ~2- to 3-fold higher mortality.
Why the study?
CAD and HF are linked with significant psychological comorbidities, primarily depression and anxiety, which remain under-recognized and undertreated in cardiac patients.
Answers are grounded in this paper and cite their sources.
This narrative review highlights the high prevalence and bidirectional pathophysiological link of depression and anxiety in patients with coronary artery disease and heart failure, underscoring the need for routine screening, enhancement of self-efficacy, and integrated multidisciplinary care to improve health-related quality of life and clinical outcomes.
Cardiovascular diseases (CVDs), encompassing coronary artery disease (CAD) and heart failure (HF), represent a leading global health burden. Beyond their profound physiological impact, these conditions are intricately linked with significant psychological comorbidities, primarily depression and anxiety. This review synthesizes current evidence regarding the prevalence, pathophysiological mechanisms, and reciprocal influences of these psychological disorders in patients with CAD and HF. It explores the crucial role of self-efficacy in mediating patient outcomes and adherence to therapeutic regimens, while also examining the profound impact of psychological distress on health-related quality of life (HRQoL). Furthermore, this article discusses evidence-based psychological interventions and pharmacological treatments, identifies key risk factors and predictors of psychological distress, and outlines clinical implications and treatment recommendations. Despite advancements, depression and anxiety in cardiac patients remain under-recognized and undertreated. This review underscores the imperative for integrated, multidisciplinary care that addresses both the physical and mental health needs of this vulnerable patient population, offering insights into limitations and future directions for research and clinical practice.
No takes yet. Share an insight, caveat, or question.
Afifuddin et al. (2026) conducted a review in Heart Failure and Coronary Artery Disease. Psychological and pharmacological interventions (Cognitive Behavioral Therapy, Exercise-Based Cardiac Rehabilitation, Motivational Interviewing, Collaborative Care, SSRIs) was evaluated. Depression and anxiety are highly prevalent in heart failure and coronary artery disease patients, conferring a 2- to 3-fold increased mortality risk.
Synapse has enriched 10 related papers. Consider them for comparative context: